$PFE.TSX Q3 '26 Earnings Results & Recap Pfizer raised full-year 2026 Revenue guidance to a range of $62B from $60.5B and raised and narrowed Adjusted diluted EPS guidance to a range of $2.95 to $3.05.
$PFE.TSX Q3 '26 Earnings Results & Recap Pfizer raised full-year 2026 Revenue guidance to a range of $62B from $60.5B and raised and narrowed Adjusted diluted EPS guidance to a range of $2.95 to $3.05.